Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN81605131
ISRCTN81605131
Completed
N/A

Therapeutic Assessment (TA) of adolescents presenting with self harm versus standard psychosocial assessment and risk management: a randomised controlled trial

South London and Maudsley NHS Trust (UK)0 sites70 target enrollmentDecember 7, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSelf harmMental and Behavioural Disordersintentional self injury

Overview

Phase
N/A
Intervention
Not specified
Conditions
Self harm
Sponsor
South London and Maudsley NHS Trust (UK)
Enrollment
70
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 7, 2007
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
South London and Maudsley NHS Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • •1\. Aged 12 \- 17 years (inclusive)
  • •2\. Presentation with self harm
  • •3\. Referral for a Child and Adolescent Mental Health Services (CAMHS) assessment

Exclusion Criteria

  • •1\. Poor English
  • •2\. Gross reality distortion due to psychosis or inebriation
  • •3\. Immediate risk of violence or suicide
  • •4\. Known moderate to severe learning disability
  • •5\. Admission to psychiatric in\-patient unit

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
N/A
TREATMENT STUDY FOR CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA - ICC APL STUDY 01
EUCTR2008-002311-40-ITA.I.E.O.P. - ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA300
Not Yet Recruiting
Phase 3
ong-Acting Treatment in Adolescents (LATA)HIV/AIDS
PACTR202302484199604niversity College London460
Active, Not Recruiting
Phase 1
Treatment study for children and adolescents with Acute Promyelocytic Leukemia
EUCTR2017-002383-40-ITAIEOP- Associazione Italiana Ematologia Oncologia Pediatrica90
Active, Not Recruiting
Phase 1
Treatment study for children and adolescents with Acute Promyelocytic Leukemia
EUCTR2017-002383-40-CZAIEOP- Associazione Italiana Ematologia Oncologia Pediatrica90
Active, Not Recruiting
Phase 1
Treatment study for children and adolescents with Acute Promyelocytic Leukemiaacute promyelocytic leukemia (APL) in children and adolescentsTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2017-002383-40-SEAIEOP- Associazione Italiana Ematologia Oncologia Pediatrica90